Zevra Therapeutics, Inc. Interest and Other Income
Zevra Therapeutics, Inc. (ZVRA) reported Interest and Other Income of $309.00 thousand for the 12-month period ending 2019-12-31, per its 10-K filed 2020-02-28.
Discontinued › Income Statement › Other Income
us-gaap:InterestAndOtherIncome · last filed 2020-02-28
- Zevra Therapeutics, Inc. interest and other income for the quarter ending 2019-12-31 was $14.00K, a 89.23% decline year-over-year.
- Zevra Therapeutics, Inc. interest and other income for the quarter ending 2019-09-30 was $60.00K, a 15.38% increase year-over-year.
- Zevra Therapeutics, Inc. interest and other income for the quarter ending 2019-06-30 was $84.00K, a 31.71% decline year-over-year.
- Zevra Therapeutics, Inc. interest and other income for the quarter ending 2019-03-31 was $151.00K, a 31.30% increase year-over-year.
- Zevra Therapeutics, Inc. interest and other income for fiscal 2019 was $309.00K, a 26.43% decline from fiscal 2018.
- Zevra Therapeutics, Inc. interest and other income for fiscal 2018 was $420.00K, a 15.07% increase from fiscal 2017.
- Zevra Therapeutics, Inc. interest and other income for fiscal 2017 was $365.00K, a 3.40% increase from fiscal 2016.
- Zevra Therapeutics, Inc. interest and other income for fiscal 2016 was $353.00K, a 1003.13% increase from fiscal 2015.
| Period end | Interest and Other Income 3 month | Interest and Other Income 6 month | Interest and Other Income 9 month | Interest and Other Income 12 month |
|---|---|---|---|---|
| 2019-12-31 | $14.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28 | $74.00K derived: sum of 2 quarters · filed 2020-02-28 | $158.00K derived: sum of 3 quarters · filed 2020-02-28 | $309.00K 10-K · filed 2020-02-28 |
| 2019-09-30 | $60.00K 10-Q · filed 2019-11-14 | $144.00K derived: sum of 2 quarters · filed 2019-11-14 | $295.00K 10-Q · filed 2019-11-14 | $425.00K derived: sum of 4 quarters · filed 2020-02-28 |
| 2019-06-30 | $84.00K 10-Q · filed 2019-08-13 | $235.00K 10-Q · filed 2019-08-13 | $365.00K derived: sum of 3 quarters · filed 2020-02-28 | $417.00K derived: sum of 4 quarters · filed 2020-02-28 |
| 2019-03-31 | $151.00K 10-Q · filed 2019-05-14 | $281.00K derived: sum of 2 quarters · filed 2020-02-28 | $333.00K derived: sum of 3 quarters · filed 2020-02-28 | $456.00K derived: sum of 4 quarters · filed 2020-02-28 |
| 2018-12-31 | $130.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28 | $182.00K derived: sum of 2 quarters · filed 2020-02-28 | $305.00K derived: sum of 3 quarters · filed 2020-02-28 | $420.00K 10-K · filed 2020-02-28 |
| 2018-09-30 | $52.00K 10-Q · filed 2019-11-14 | $175.00K derived: sum of 2 quarters · filed 2019-11-14 | $290.00K 10-Q · filed 2019-11-14 | $387.00K derived: sum of 4 quarters · filed 2019-11-14 |
| 2018-06-30 | $123.00K 10-Q · filed 2019-08-13 | $238.00K 10-Q · filed 2019-08-13 | $335.00K derived: sum of 3 quarters · filed 2019-08-13 | $489.00K derived: sum of 4 quarters · filed 2019-08-13 |
| 2018-03-31 | $115.00K 10-Q · filed 2019-05-14 | $212.00K derived: sum of 2 quarters · filed 2019-05-14 | $366.00K derived: sum of 3 quarters · filed 2019-05-14 | $379.00K derived: sum of 4 quarters · filed 2019-05-14 |
| 2017-12-31 | $97.00K 10-K · filed 2018-03-30 | $251.00K derived: sum of 2 quarters · filed 2018-11-09 | $264.00K derived: sum of 3 quarters · filed 2018-11-09 | $365.00K 10-K · filed 2019-03-01 |
| 2017-09-30 | $154.00K 10-Q · filed 2018-11-09 | $167.00K derived: sum of 2 quarters · filed 2018-11-09 | $268.00K 10-Q · filed 2018-11-09 | $277.00K derived: sum of 4 quarters · filed 2018-11-09 |
| 2017-06-30 | $13.00K 10-Q · filed 2018-08-10 | $114.00K 10-Q · filed 2018-08-10 | $123.00K derived: sum of 3 quarters · filed 2018-08-10 | $221.00K derived: sum of 4 quarters · filed 2018-08-10 |
| 2017-03-31 | $101.00K 10-Q · filed 2018-05-11 | $110.00K derived: sum of 2 quarters · filed 2018-05-11 | $208.00K derived: sum of 3 quarters · filed 2018-05-11 | $352.00K derived: sum of 4 quarters · filed 2018-05-11 |
| 2016-12-31 | $9.00K 10-K · filed 2018-03-30 | $107.00K derived: sum of 2 quarters · filed 2018-03-30 | $251.00K derived: sum of 3 quarters · filed 2018-03-30 | $353.00K 10-K · filed 2018-03-30 |
| 2016-09-30 | $98.00K 10-K · filed 2018-03-30 | $242.00K derived: sum of 2 quarters · filed 2018-03-30 | $344.00K 10-Q · filed 2017-11-09 | $359.00K derived: sum of 4 quarters · filed 2018-03-30 |
| 2016-06-30 | $144.00K 10-K · filed 2018-03-30 | $246.00K 10-Q · filed 2017-08-10 | $261.00K derived: sum of 3 quarters · filed 2018-03-30 | $272.00K derived: sum of 4 quarters · filed 2018-03-30 |
| 2016-03-31 | $102.00K 10-K · filed 2018-03-30 | $117.00K derived: sum of 2 quarters · filed 2018-03-30 | $128.00K derived: sum of 3 quarters · filed 2018-03-30 | $133.00K derived: sum of 4 quarters · filed 2018-03-30 |
| 2015-12-31 | $15.00K 10-K · filed 2017-03-10 | $26.00K derived: sum of 2 quarters · filed 2017-03-10 | $31.00K derived: sum of 3 quarters · filed 2017-03-10 | $32.00K 10-K · filed 2018-03-30 |
| 2015-09-30 | $11.00K 10-K · filed 2017-03-10 | $16.00K derived: sum of 2 quarters · filed 2017-03-10 | $17.00K 10-Q · filed 2016-11-10 | |
| 2015-06-30 | $5.00K 10-K · filed 2017-03-10 | $6.00K 10-Q · filed 2016-08-11 | ||
| 2014-12-31 | $4.00K 10-K · filed 2016-03-16 | $7.00K derived: sum of 2 quarters · filed 2016-03-16 | $8.00K 10-K · filed 2017-03-10 | |
| 2014-09-30 | $3.00K 10-K · filed 2016-03-16 | $3.00K 10-Q · filed 2015-11-13 | ||
| 2013-12-31 | $52.00K 10-K · filed 2016-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |